Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

UV exposure harms skin by causing fibroblast loss, but T cells help fibroblast survival.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Alopecia areata is caused by the immune system attacking hair follicles.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.